Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,464 | -3,970 | -14,050 | -11,770 | -10,440 |
| Depreciation Amortization | 99 | 49 | 1,810 | 1,350 | 890 |
| Accounts payable and accrued liabilities | 405 | 236 | 359 | N/A | N/A |
| Other Working Capital | 3,793 | 3,225 | -3,010 | -40 | -60 |
| Other Operating Activity | 1,040 | 513 | 3,831 | 4,690 | 6,290 |
| Operating Cash Flow | $-3,127 | $53 | $-11,060 | $-5,770 | $-3,320 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -113 | -61 | -610 | -480 | -340 |
| Other Investing Activity | 0 | 0 | -130 | -130 | -120 |
| Investing Cash Flow | $-113 | $-61 | $-740 | $-610 | $-460 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 137 | 49 | 110 | N/A | N/A |
| Common Stock Issued | N/A | N/A | 21,154 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -4 | 21,150 | 21,160 |
| Financing Cash Flow | $137 | $49 | $21,260 | $21,150 | $21,160 |
| Beginning Cash Position | 12,020 | 12,020 | 2,560 | 2,560 | 2,560 |
| End Cash Position | 8,918 | 12,061 | 12,020 | 17,320 | 19,930 |
| Net Cash Flow | $-3,102 | $41 | $9,450 | $14,760 | $17,370 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,127 | 53 | -11,060 | -5,770 | -3,320 |
| Capital Expenditure | -113 | -61 | -619 | N/A | N/A |
| Free Cash Flow | -3,239 | -8 | -11,679 | -5,770 | -3,320 |